Search Results

Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: a randomized, multicenter, double-... by Mösges, Ralph (Author) , Bachert, C. (Author) , Panzner, P. (Author) , Calderon, M. A. (Author) , Haazen, L. (Author) , Pirotton, S. (Author) , Wathelet, N. (Author) , Durham, S. R. (Author) , Bonny, M.-A. (Author) , Legon, T. (Author) , von Frenckell, R. (Author) , Pfaar, Oliver (Author) , Shamji, M. H. (Author) ,

• Verlag, lizenzpflichtig, Volltext

Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study by Klimek, Ludger (Author) , Schendzielorz, Philipp (Author) , Pfaar, Oliver (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study by Pfaar, Oliver (Author) , Barth, Christine (Author) , Jaschke, Christine (Author) , Hörmann, Karl (Author) , Klimek, Ludger (Author) ,

• Verlag, lizenzpflichtig, Volltext

Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? by Pfaar, Oliver (Author) , Kleine-Tebbe, Jörg (Author) , Hörmann, Karl (Author) , Klimek, Ludger (Author) ,

• Verlag, lizenzpflichtig, Volltext